Chester County News and Community Website
WEST BRANDYWINE, PA — Freedom Village at Brandywine employees raised $1,223 for the Alzheimer’s Association during the community’s second annual Alzheimer’s Awareness Car Wash on June 29, turning an afternoon …
Freedom Village Car Wash Raises More Than $1,200 for Alzheimer’s Association Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has completed enrollment in its pivotal Phase 3 Alzheimer’s disease trial, positioning the biotechnology company for two planned U.S. regulatory submissions beginning …
Annovis Completes Enrollment for Alzheimer’s Phase 3 Trial Read More
The chessboard sits untouched for a moment. Sunlight spills across the kitchen table as a retired accountant studies the position in front of him. His morning coffee has gone cold. …
Men’s Health Month Has a Message Many Men Need to Hear Read More
PHOENIXVILLE, PA — Music, memory, and community connection will take center stage this summer as Good Vibrations for a Cure returns to The Colonial Theatre for its second annual fundraiser …
Phoenixville Fundraiser Honors Brian Wilson Through Music, Healing, and Alzheimer’s Awareness Read More
HARRISBURG, PA — Pennsylvania researchers can now apply for $5 million in state funding aimed at advancing treatments and potential cures for neurodegenerative diseases affecting hundreds of thousands of residents.
PA Opens $5M Grant Push to Fight Alzheimer’s, ALS, Parkinson’s Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) announced the publication of an article detailing the development of its lead drug candidate buntanetap as the company continues clinical trials for …
Annovis Bio Highlights Buntanetap Development in Published Article Read More
FAIRLESS HILLS, PA — The Silvi Foundation announced its launch as a nonprofit organization focused on supporting research into Alzheimer’s disease, dementia, ALS, Parkinson’s disease, and other neurodegenerative conditions.
Silvi Foundation Launches With $100,000 Grant for Neurodegenerative Research Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) announced that an independent Data and Safety Monitoring Board has recommended continuation of its ongoing Phase 3 clinical trial of buntanetap in …
Malvern-Based Annovis Continues Phase 3 Alzheimer’s Trial After Safety Review Read More
GENT, Belgium & MALVERN, PA & TOKYO, Japan — A new laboratory test aimed at detecting Alzheimer’s disease earlier in its progression is now available to researchers, marking a potential …
New Alzheimer’s Biomarker Test Debuts, Promising Earlier, Faster Detection Read More
HARRISBURG, PA — Pennsylvania is making a major investment in the fight against Alzheimer’s, Parkinson’s, ALS, and other neurodegenerative diseases, unveiling a $5 million research initiative that officials say will …
State Boosts Brain Research: New $5 Million Push Aims to Unlock Hope for Families Read More